Author: Alatrash Gheath Jakher Haroon Stafford Patricia D Mittendorf Elizabeth A
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.12, Iss.5, 2013-09, pp. : 631-645
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Immunotherapies for cancer reviewed
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
Advances in Prostate Cancer Immunotherapies
By Basler Michael Groettrup Marcus
Drugs & Aging, Vol. 24, Iss. 3, 2007-01 ,pp. :
Emerging Immunotargets and Immunotherapies in Prostate Cancer
Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. :
Nanotechnology in Drug Delivery: Safety and Toxicity Issues
Current Pharmaceutical Design, Vol. 21, Iss. 29, 2015-10 ,pp. :